Finnzymes Buy to Enhance Thermo Fisher's qPCR Reagent, Instrument Plays

The acquisition may also provide Thermo Fisher with a foothold in the rapidly growing PCR-based molecular diagnostics market, according to a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.